PharmaCyte Biotech Inc

PharmaCyte Biotech, Inc. is a biotechnology company focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. Its therapies are based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation platform for treating various cancers, and it also develops CypCaps for pancreatic cancer and other solid tumors. The company has a cooperation agreement with Iroquois Master Fund Ltd. and license agreements with SG Austria Pte. Ltd. and Austrianova Singapore Pte. Ltd. for the Cell-in-the-Box technology. Formerly known as Nuvilex, Inc., it changed its name to PharmaCyte Biotech, Inc. in January 2015, was incorporated in 1996, and is headquartered in Las Vegas, Nevada.